U.S. Food and Drug Administration Drug Approval Summaries: Imatinib Mesylate, Mesna Tablets, and Zoledronic AcidMartin H. Cohen, Richard Pazdur, Donna Griebel et al.|The Oncologist|2002Cited by 56